Document is current
Any future updates will be listed below
-
Authors
Rozemeijer, Sander https://orcid.org/0000-0002-1185-4373
de Grooth, Harm-Jan
Elbers, Paul W. G.
Girbes, Armand R. J.
den Uil, Corstiaan A.
Dubois, Eric A.
Wils, Evert-Jan
Rettig, Thijs C. D.
van Zanten, Arthur R. H.
Vink, Roel
van den Bogaard, Bas
Bosman, Rob J.
Oudemans-van Straaten, Heleen M.
de Man, Angélique M. E.
-
Funding
Funding for this research was provided by:
ZonMw (848081001)
- License Information
-
More Information
Article History
Received: 12 April 2021
Accepted: 23 July 2021
First Online: 18 August 2021
Declarations
:
: The study was approved by the ethics committee at Amsterdam UMC, location VUmc (VU University Medical Centre Protocol Record METC-2018.120). The ethics committee approved to start with study interventions before informed consent is obtained to avoid treatment delay. The legal representative will be informed and asked for informed consent (“deferred informed proxy consent”) by the investigator or the treating physician within 72 h after ICU admission. If informed consent cannot be obtained within 72 h, the patient will be excluded, and data will no longer be used. The participant will be, if recovered, informed about participation in the study. The patient is free to fill in a withdrawal form and can decide to remove the collected data and body material. All substantial protocol amendments will be submitted to the Central Committee on Research Involving Human Subjects and the Medical Ethics Committee of Amsterdam UMC, location VUmc. Approved amendments will be communicated with the principal investigators of the participating hospitals.
: Not applicable.
: The authors declare that they have no competing interests.
